Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Galli

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Antiviral Therapy|May 29, 2009
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patientsAlessandro Soria, Klaudia Porten, Jean-Calvin Fampou-Toundji, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2023
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective studyIli Margalit, Giusy Tiseo, Marco Ripa, et al.
Microbiology Spectrum|September 11, 2025
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO RegistryVincenzo Spagnuolo, Laura Galli, Jiani Li, et al.
Journal of Medical Virology|January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapyNicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
Viruses|August 10, 2021
Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot StudyRossana Scutari, Valentino Costabile, Laura Galli, et al.
Medicine and Science in Sports and Exercise|August 16, 2019
A Mobile Application for Exercise Intervention in People Living with HIVMatteo Bonato, Filippo Turrini, Valentina DE Zan, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2016
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trialLaura Galli, Vincenzo Spagnuolo, Alba Bigoloni, et al.
Drug Design, Development and Therapy|October 21, 2022
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort StudyVincenzo Spagnuolo, Marta Voarino, Marco Tonelli, et al.
BMJ Open|August 13, 2025
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease researchMarco Ripa, Laura Galli, Paola Cinque, et al.
Infectious Diseases (London, England)|January 25, 2023
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultationValentina Da Prat, Laura Galli, Paola Cichero, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Antiviral Therapy|May 29, 2009
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patientsAlessandro Soria, Klaudia Porten, Jean-Calvin Fampou-Toundji, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2023
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective studyIli Margalit, Giusy Tiseo, Marco Ripa, et al.
Microbiology Spectrum|September 11, 2025
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO RegistryVincenzo Spagnuolo, Laura Galli, Jiani Li, et al.
Journal of Medical Virology|January 26, 2011
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapyNicola Gianotti, Laura Galli, Maurizio Zazzi, et al.
Viruses|August 10, 2021
Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot StudyRossana Scutari, Valentino Costabile, Laura Galli, et al.
Medicine and Science in Sports and Exercise|August 16, 2019
A Mobile Application for Exercise Intervention in People Living with HIVMatteo Bonato, Filippo Turrini, Valentina DE Zan, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2016
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trialLaura Galli, Vincenzo Spagnuolo, Alba Bigoloni, et al.
Drug Design, Development and Therapy|October 21, 2022
Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort StudyVincenzo Spagnuolo, Marta Voarino, Marco Tonelli, et al.
BMJ Open|August 13, 2025
The INfectious DIsease REgistry BIObank (INDI-REBIO): protocol for the design and implementation of a single-centre, prospective registry and biobank in a tertiary care centre in Italy for advancing infectious disease researchMarco Ripa, Laura Galli, Paola Cinque, et al.
Infectious Diseases (London, England)|January 25, 2023
Antibiotic appropriateness for Gram-negative bloodstream infections: impact of infectious disease consultationValentina Da Prat, Laura Galli, Paola Cichero, et al.
Pageof 18